Graft coronary disease: Old and new dimensions

Cardiovascular Pathology

Volumn 6, Issue 2, 1997, Pages 95-101

  Billingham, Margaret E ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CELL ADHESION MOLECULE; CYCLOSPORIN; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 2; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLATELET DERIVED GROWTH FACTOR; RAPAMYCIN; TACROLIMUS; TUMOR GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; CHILD; CONFERENCE PAPER; CORONARY ARTERY BYPASS GRAFT; CYTOMEGALOVIRUS; DIABETES MELLITUS; ENDOTHELIUM CELL; FEMALE; HEART TRANSPLANTATION; HISTOLOGY; HUMAN; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VASCULAR DISEASE;

EID: 0030964818     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1054-8807(96)00089-0     Document Type: Conference Paper

References (47)

1. Hosenpud JD. The Registry of the International Society for Heart and Lung Transplantation: Thirteenth Official Report. J Heart and Lung Transplantation 1996;15:655.
2. Billingham ME. Cardiac transplant atherosclerosis. Transplant Proc 1987 (XIX);4:19-25.
3. Billingham ME. Graft coronary disease: The lesions and the patients. Transplant Proc 1989;21:3665-3666.
4. Billingham ME. Pathobiology and etiology of chronic rejection of the heart. Clin Transplantation 1994;8:289-292.
5. Richenbacher PR, Pinto FJ, Chenzbraun A, et al. Incidence and severity of transplant artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound. J Am Coll Cardiol 1995;25:171-177.
6. Heroux AL, Silverman P, Costanzo MR, et al. Intracoronary ultrasound assessment of morphological and functional abnormalities associated with cardiac allograft vasculopathy Circulation 1994;89:272-277.
7. Kushwaha SS, Bustami M, Lythall DA, et al. Coronary endothelial function in cardiac transplant recipients with accelerated coronary disease. Coronary Artery Disease 1994;5:147-154.
8. Hammond EH, Yowell RL, Nunoda S, et al. Vascular (humoral) rejection in heart transplantation: Pathologic observations and clinical implications. J Heart Transpl 1989;8:430-443.
9. Pucci AM, Forbes C, Billingham ME. Pathologic features in long term cardiac allografts. J Heart Transpl 1990;9:339-345.
10. Hruban RH, Beschorner WE, Baumgartner WA. Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte mediated endothelialitis. Am J Pathol 1990;137:871-882.
11. Russell ME, Fujita M, Masek MA, et al. Cardiac graft vascular disease: nonselective involvement of large and small vessels. Transplantation 1993;56:762-764.
12. Fujita M, Russell ME, Masek MA, et al. Graft vascular disease in the great vessels and vasa vasorum. Human Pathol 1993;24:1067-1072.
13. Joshi A, Oyer PE, Berry GJ, Billingham ME. Heart-lung Transplantation: cardiac clinicopathologic correlations. J Cardiovasc Path 1996;5:153-158.
14. Gao SZ, Alderman EL, Schroeder JS, Silverman JF, Hunt SA. Accelerated coronary vascular disease in the heart transplant patient: coronary angiographic findings. J Am Coll Cardiol 1988;12:334-340.
15. Gao SZ, Schroeder JS, Alderman EL, et al. Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient. Circulation 1987;76:V56-61.
16. Cave MH, Sharpies LD, Wallwork J. Chronic rejection in human allografts: Clinical correlations. In: Orosz CG, Sedmark DD, Ferguson RM, eds. Transplant Vascular Sclerosis. Austin, TX: R. G. Landes, 1995:45-51.
17. Schmid C, Heemann U, Azuma M, Tilney NL. Transplant vasculopathy in rat heart transplantation - A morphologic chameleon determined by antigen-dependent and independent factors. Transpl Proc 1995;27:2007-2079.
18. Schoen FJ, Libby P. Cardiac transplant arteriosclerosis. Trends Cardiovasc Med 1991;1:216-223.
19. Billingham ME, Baumgartner WA, Watson DC, Reitz BA, et al. Distant heart procurement for human transplantation: Ultrastructural studies. Circulation 1980;62(suppl 1):1-11.
20. Masetti P, DiSesa VJ, Schoen FJ, et al. Ischemic injury before heart transplantation does not cause transplant arteriopathy in experimental isografts. J Heart Transpl 1991;10:597-599.
21. Radley-Smith RC, Yacoub MH. Long term results of pediatric transplantation. J Heart Lung Transplant 1992;11:S277-281.
22. Sharples LD, Caine N, Mullins P, et al. Risk factor analysis for the major hazards following heart transplantation - Rejection, infection and coronary occlusive disease. Transplantation 1991;52:244-252.
23. Reichart B, Meiser B. Graft vessel disease after heart transplantation. In: Orosz CG, Sedmark DD, Ferguson RM, eds. Transplant Vascular Sclerosis. Austin, TX: RG Landes, 1995:1-5.
24. Keogh A, Simons L, Spratt P, et al. Hyperlipidemia after heart transplantation. J Heart Transplant 1988;7:171-175.
25. Meiser BM, Wenke K, Thiery J, Wolf S, et al. Simvastin decreases accelerated graft vessel disease after heart transplantation in an animal model. Transplant Proc 1993;25:2077.
26. Thiery J, Meiser B, Wenke K, et al. Heparin-induced extracorporeal low density lipoprotein plasmapheresis (HELP) and its use in heart transplant patients with severe hypercholesterolemia. Transplant Proc 1995;27:1950-1953.
27. Foegh ML, Khirbadi BS, Chambers E, et al. Inhibition of coronary artery transplant atherosclerosis in rabbits with angiopeptin, an octapeptid. Atherosclerosis 1989;78:229-236.
28. Foegh ML, Rego A, Lou H, et al. Gender effects on graft myointimal hyperplasia. Transplant Proc 1995;27:2070-2072.
29. Gratton MT, Moreno-Cabral CE, Starnes VA, et al. Cytomegalovirus is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989;261:3561-3566.
30. Bonnaud EN, Lewis NP, Masek MA, Billingham ME. Reliability and Usefulness of immunofluorescence in heart transplantation. J Heart Lung Transplant 1995;14:163-171.
31. Hosenpud JD, Everett JP, Morris TE, et al. Cardiac allograft vasculopathy association with cell-mediated but not humoral alloimmunity to donor specific vascular endothelium. Circulation 1995;92:205-211.
32. Tilney NL. New horizons in renal transplantation (letter). Transplantation and Immunology (special issue) 1996:3.
33. Petrossian GA, Nichols AB, Marboe CC, et al. Relation between survival and development of coronary artery disease and anti-HLA antibodies after cardiac transplant. Circulation 1989;80(suppl 3):122-125.
34. Tilney NL, Whitely WD, Diamond JR, et al. Chronic rejection - An undefined conundrum. Transplantation 1991;52:389-398.
35. Libby P, Tanaka H. The pathogenesis of coronary arteriosclerosis ("chronic rejection") in transplanted hearts. Clin Transplantation 1994;8:313-318.
36. Raines EW, Ross R. Platelet derived growth factor in vivo. In: Westermark B, Sorg C, eds. Cytokines, Vol. 5: Biology of PDGF. Basel: S Karger AG, 1993:74-114.
37. Ferns GAA, Raines EW, Sprugel KH, et al. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991;253:1129-1132.
38. Clinton SK, Libby P. Cytokines and growth factors in atherogenesis. Arch Pathol Lab Med 1992;116:1292-1300.
39. Gregory CR, Huang X, Pratt RE, Dzau VJ, et al. Treatment with rapamycin and mycophenylate acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. Transplantation 1995;59:655-661.
40. Gregory CR, Pratt RE, Huie P, Shorthouse R, et al. Effect of treatment with cyclosporine, FK506, rapamycin, mycophenolic acid or deoxyspergualin on vascular muscle proliferation in vitro or in vivo. Transplant Proc 1993;25:770-771.
41. Ferns GA, Raines EW, Sprugel KH, et al. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991;253:1129.
42. Orosz CG, Ohye RG, Pelletier RP, et al. Treatment with anti-vascular adhesion molecule 1 monoclonal antibody induces long term murine cardiac allograft acceptance. Transplant 1993;56:453.
43. Gao SZ, Alderman EL, Schroeder JS, et al. Accelerated coronary vascular disease in the heart transplant patient: coronary angiographic findings. J Am Coll Cardiol 1988;12:334-340.
44. Richenbacher PR, Pinto FJ, Chenzbraun A, et al. Incidence and severity of transplant artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound. J Am Coll Cardiol 1995;25:171-177.
45. Chauhan A, Mullins PA, Thuraingham S, et al. Coronary flow reserve measurement with a new Judkins-Stule Doppler angiographic catheter. Angiology 1993;44:939-944.
46. White D. Cardiac xenotransplantation. Ann Card Surg 1993;6:167-171.
47. Orloff MS, DeMara EM, Coppage ML, et al. Prevention of chronic rejection and graft arteriosclerosis by tolerance induction. Transplantation 1995;59:282-288.